Most Recent
Pfizer faces class action investigation into Depo-Provera
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
‘Truly lamentable’: Solicitors score partial win in tax appeal
Two Queensland solicitors have scored partial wins in their decades-long disputes with the tax office because of the Administrative Appeals Tribunal’s “wholesale failure” to give proper reasons.
IP firm loses challenge to Apple’s authentication patent
An intellectual property firm has lost its legal challenge to Apple's bid to patent its method of authentication on electronic devices, including smartphones.
ASIC can bring case against Rex Airlines, directors
ASIC has won approval to bring claims against troubled regional airline Rex and four of its directors for allegedly misleading investors about the company's financial position.
Top 10 class action settlements of 2024
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
High Court asked to weigh in on Katy Perry trade mark stoush
An Australian fashion designer has asked the High Court to overturn a Full Court win for singer Katy Perry in a long-running trade mark dispute, saying the court's findings “wrongly privilege the powerful and famous over ordinary traders”.
Toyota unit Hino to pay $87M to settle emissions cheating class action
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Tougher penalties floated for improper legal privilege claims
The government has proposed tougher penalties to crack down on the improper use of legal professional privilege claims in Commonwealth investigations.
Dominique Grubisa, Master Wealth lose challenge to $6M penalty
The Full Court has rejected wealth guru Dominique Grubisa's argument that a judge who slapped her and her company with a $6 million penalty wrongly confused the ordinary consumer with “the most ignorant”.
‘Considerable disquiet’: Pelvic mesh group members can challenge $405M settlements
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.